Testing Trendline

Biotech never made it to the 99.75-area from the last update.

However, it did post an up-thrust, topping out at 99.65, just 0.10-pts from target.

This is how it is … for the scientific types, good luck with calculating where the market ‘should’ go. 🙂

Evidently, getting within 0.10-points from a 38.2% retrace was ‘good enough’; XBI reversed from there.

Biotech XBI, Daily

If this is a trendline of some importance, we’re still in the very early stages (not advice, not a recommendation).

Anything can happen and XBI, could close higher.

A new daily low was posted early in the session and price action is currently attempting to ‘spring’ off that low.

Positioning

As noted, a short is open (LABD-24-19); it may be a ‘day trade’ if XBI does not close lower for the day (not advice, not a recommendation).

Separately, based on price action, SOXS-24-17, was closed with a 13.1%, profit (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279